Trading With A Small Account?

From Tradewins | Ad

If you’ve been told it’s not doable, you’ve been lied to! Hi, I’m pro-trader Chuck Hughes and I grew my once tiny investment into an empire!

If you want to do the same–or simply want to feel more secure in your finances–”Options Trading Made Easy” is the guide you need.

Get a copy here!

>>>

EXEL Insider Trading (Exelixis)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,208,406.43

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$20.82

▲ +0.03 (0.14%)

As of 06/30/2022 05:00 PM ET

Days: 30 | 90 | 365

Better Options For Trading!

From Tradewins | Ad

I know–you’ve heard options trading is tough, but is it really tougher than the market is right now?

NO! “Options Trading Made Easy” by pro-trader Chuck Hughes gives traders the best options in an unpredictable market…

Get your copy now!

>>>

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/27/2022	Patrick J Haley	EVP	Sell	18,812	$18.21	$342,566.52	239,818
5/12/2022	Lance Willsey	Director	Sell	40,000	$19.65	$786,000.00	424,415
4/4/2022	Jack L Wyszomierski	Director	Sell	6,696	$23.00	$154,008.00	273,192
3/31/2022	Patrick J Haley	EVP	Sell	10,000	$22.43	$224,300.00	269,191
3/28/2022	Jeffrey J. Hessekiel	EVP	Sell	4,717	$22.00	$103,774.00
3/1/2022	Alan M. Garber	Director	Sell	21,301	$21.00	$447,321.00
2/24/2022	Jeffrey J. Hessekiel	EVP	Sell	18,000	$20.00	$360,000.00
2/22/2022	Stelios Papadopoulos	Director	Sell	84,515	$19.56	$1,653,113.40
2/3/2022	Patrick J Haley	EVP	Sell	60,000	$17.91	$1,074,600.00
12/15/2021	Peter Lamb	EVP	Sell	47,500	$17.44	$828,400.00
11/24/2021	Patrick J Haley	EVP	Sell	17,236	$17.25	$297,321.00
11/19/2021	Carl B. Feldbaum	Director	Sell	20,000	$17.62	$352,400.00
11/15/2021	Peter Lamb	EVP	Sell	47,500	$18.09	$859,275.00
11/1/2021	Jeffrey J. Hessekiel	EVP	Sell	5,117	$22.03	$112,727.51
10/15/2021	Peter Lamb	EVP	Sell	47,500	$21.92	$1,041,200.00
9/16/2021	Patrick J. Haley	EVP	Sell	25,000	$20.36	$509,000.00
8/16/2021	Peter Lamb	EVP	Sell	55,000	$18.44	$1,014,200.00
7/15/2021	Peter Lamb	EVP	Sell	60,000	$17.47	$1,048,200.00
6/17/2021	Peter Lamb	EVP	Sell	60,000	$22.18	$1,330,800.00
5/18/2021	Patrick J. Haley	EVP	Sell	14,593	$24.73	$360,884.89
5/14/2021	Vincent T. Marchesi	Director	Sell	40,000	$25.04	$1,001,600.00
5/13/2021	Gisela Schwab	CMO	Sell	100,000	$25.38	$2,538,000.00
5/11/2021	Stelios Papadopoulos	Director	Sell	20,770	$24.98	$518,834.60
4/26/2021	Gisela Schwab	CMO	Sell	50,000	$25.00	$1,250,000.00
4/26/2021	Patrick J. Haley	EVP	Sell	7,665	$25.03	$191,854.95
4/1/2021	Gisela Schwab	CMO	Sell	50,000	$23.00	$1,150,000.00
4/1/2021	Peter Lamb	EVP	Sell	60,000	$22.96	$1,377,600.00
3/29/2021	Jack L. Wyszomierski	Director	Sell	6,220	$22.64	$140,820.80
3/15/2021	Alan M. Garber	Director	Sell	40,000	$23.60	$944,000.00	52,718
3/1/2021	Peter Lamb	EVP	Sell	65,000	$22.11	$1,437,150.00
2/24/2021	Charles Cohen	Director	Sell	40,000	$22.69	$907,600.00	221,375
2/22/2021	Vincent T. Marchesi	Director	Sell	24,097	$22.29	$537,122.13	424,415
2/17/2021	Gisela Schwab	CMO	Sell	50,000	$22.50	$1,125,000.00
2/16/2021	Carl B. Feldbaum	Director	Sell	20,000	$21.96	$439,200.00	28,521
2/12/2021	Patrick J. Haley	EVP	Sell	45,000	$21.57	$970,650.00
2/1/2021	Peter Lamb	EVP	Sell	65,000	$22.08	$1,435,200.00
1/12/2021	Christopher J. Senner	CFO	Sell	30,000	$25.00	$750,000.00
1/4/2021	Peter Lamb	EVP	Sell	65,000	$20.32	$1,320,800.00
12/18/2020	Peter Lamb	EVP	Sell	65,000	$20.01	$1,300,650.00
11/24/2020	Vincent T. Marchesi	Director	Sell	40,004	$18.50	$740,074.00
11/10/2020	Jack L. Wyszomierski	Director	Sell	34,000	$20.61	$700,740.00
10/21/2020	Jeffrey J. Hessekiel	EVP	Sell	39,742	$21.95	$872,336.90
10/8/2020	Christopher J. Senner	CFO	Sell	10,000	$25.00	$250,000.00
9/21/2020	Patrick J. Haley	EVP	Sell	4,680	$26.09	$122,101.20
9/15/2020	Christopher J. Senner	CFO	Sell	20,000	$25.00	$500,000.00
7/20/2020	Patrick J. Haley	EVP	Sell	3,151	$25.36	$79,909.36
6/8/2020	Peter Lamb	EVP	Sell	26,000	$22.56	$586,560.00
6/4/2020	Gisela Schwab	CMO	Sell	100,000	$22.96	$2,296,000.00
5/21/2020	Vincent T. Marchesi	Director	Sell	40,000	$24.64	$985,600.00	12,718
5/20/2020	Patrick J. Haley	EVP	Sell	3,151	$24.99	$78,743.49
5/18/2020	Lance Willsey	Director	Sell	30,000	$26.26	$787,800.00	398,273
5/14/2020	Lance Willsey	Director	Sell	15,000	$25.26	$378,900.00	383,273
5/11/2020	Jeffrey J. Hessekiel	EVP	Sell	38,006	$27.09	$1,029,582.54
5/11/2020	Vincent T. Marchesi	Director	Sell	30,000	$26.30	$789,000.00
5/8/2020	Patrick J. Haley	EVP	Sell	21,375	$25.87	$552,971.25
5/8/2020	Stelios Papadopoulos	Director	Sell	45,000	$25.84	$1,162,800.00
5/7/2020	Christopher J. Senner	CFO	Sell	21,417	$25.80	$552,558.60
4/24/2020	George A Scangos	Director	Sell	15,000	$26.24	$393,600.00	808,731
4/23/2020	Gisela Schwab	CMO	Sell	100,000	$26.00	$2,600,000.00
4/23/2020	Patrick J. Haley	EVP	Sell	5,000	$26.00	$130,000.00
4/22/2020	George A Scangos	Director	Sell	4,200	$25.05	$105,210.00	894,531
4/20/2020	George A Scangos	Director	Sell	50,000	$23.89	$1,194,500.00	894,531
4/20/2020	Patrick J. Haley	EVP	Sell	5,000	$24.00	$120,000.00
4/15/2020	George A Scangos	Director	Sell	25,000	$18.31	$457,750.00	913,031
4/7/2020	George A Scangos	Director	Sell	16,435	$18.25	$299,938.75	945,096
4/6/2020	Peter Lamb	EVP	Sell	50,000	$17.26	$863,000.00
4/3/2020	Jack L. Wyszomierski	Director	Sell	13,848	$16.57	$229,461.36
3/31/2020	George A Scangos	Director	Sell	1,500	$18.06	$27,090.00	961,531
3/20/2020	Patrick J. Haley	EVP	Sell	4,318	$15.37	$66,367.66
3/4/2020	Gisela Schwab	CMO	Sell	100,000	$19.40	$1,940,000.00
3/3/2020	Carl B. Feldbaum	Director	Sell	38,000	$18.84	$715,920.00	40,521
2/26/2020	Michael Morrissey	CEO	Sell	25,000	$18.91	$472,750.00
2/19/2020	Gisela Schwab	CMO	Sell	40,000	$21.50	$860,000.00
2/19/2020	Michael Morrissey	CEO	Sell	25,000	$21.75	$543,750.00
2/19/2020	Patrick J. Haley	EVP	Sell	5,000	$22.00	$110,000.00
2/18/2020	George A Scangos	Director	Sell	50,000	$20.73	$1,036,500.00	963,031
2/14/2020	Alan M. Garber	Director	Sell	12,500	$21.02	$262,750.00	48,829
2/13/2020	Michael Morrissey	CEO	Sell	25,000	$20.11	$502,750.00
2/11/2020	George A Scangos	Director	Sell	4,000	$20.14	$80,560.00	1,034,031
2/7/2020	Gisela Schwab	CMO	Sell	50,000	$18.37	$918,500.00
1/29/2020	Michael Morrissey	CEO	Sell	25,000	$17.87	$446,750.00
1/23/2020	Michael Morrissey	CEO	Sell	25,000	$19.41	$485,250.00	1,038,031
1/16/2020	Michael Morrissey	CEO	Sell	25,000	$20.33	$508,250.00
1/15/2020	Vincent T. Marchesi	Director	Sell	61,683	$20.01	$1,234,276.83
1/8/2020	Michael Morrissey	CEO	Sell	25,000	$18.85	$471,250.00
1/7/2020	Alan M. Garber	Director	Sell	86,956	$18.01	$1,566,077.56	91,329
1/7/2020	Gisela Schwab	CMO	Sell	50,000	$17.96	$898,000.00
1/2/2020	Michael Morrissey	CEO	Sell	25,000	$17.49	$437,250.00
12/3/2019	Gisela Schwab	CMO	Sell	50,000	$17.36	$868,000.00
11/4/2019	Gisela Schwab	CMO	Sell	50,000	$15.99	$799,500.00
10/10/2019	Patrick J. Haley	VP	Sell	303	$16.27	$4,929.81
10/2/2019	Michael Morrissey	CEO	Sell	26,364	$17.66	$465,588.24
10/1/2019	Gisela Schwab	CMO	Sell	30,000	$17.87	$536,100.00
9/18/2019	Michael Morrissey	CEO	Sell	37,227	$19.20	$714,758.40
9/10/2019	Patrick J. Haley	VP	Sell	1,000	$18.84	$18,840.00
8/16/2019	George Poste	Director	Sell	25,000	$20.50	$512,500.00
8/16/2019	Jeffrey J. Hessekiel	EVP	Sell	75,000	$21.10	$1,582,500.00
8/14/2019	Michael Morrissey	CEO	Sell	35,040	$20.11	$704,654.40
8/12/2019	Patrick J. Haley	VP	Sell	1,000	$20.39	$20,390.00
8/9/2019	George Poste	Director	Sell	20,000	$20.60	$412,000.00
8/6/2019	Patrick J. Haley	Insider	Sell	25,000	$20.02	$500,500.00
8/2/2019	Michael Morrissey	Insider	Sell	35,040	$20.25	$709,560.00
8/1/2019	George A Scangos	Director	Sell	40,000	$20.59	$823,600.00	1,134,081
7/17/2019	Michael Morrissey	CEO	Sell	34,721	$21.37	$741,987.77
7/10/2019	Patrick J. Haley	Insider	Sell	1,000	$20.96	$20,960.00
7/3/2019	Michael Morrissey	CEO	Sell	34,721	$21.03	$730,182.63
7/1/2019	George A Scangos	Director	Sell	40,000	$21.58	$863,200.00	1,168,031

Better Options For Trading!

From Tradewins | Ad

>>>

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

82.74% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/30/2022	Amalgamated Bank	232,559	$5.27M	0.0%	-0.5%	0.073%
6/7/2022	Teachers Retirement System of The State of Kentucky	36,800	$0.83M	0.0%	-7.5%	0.011%
6/7/2022	Bank of America Corp DE	1,213,210	$27.50M	0.0%	+36.0%	0.378%
5/27/2022	Walleye Capital LLC	35,925	$0.81M	0.0%	+105.3%	0.011%
5/26/2022	Rice Hall James & Associates LLC	87,298	$1.98M	0.1%	-4.8%	0.027%
5/23/2022	Neuberger Berman Group LLC	17,357	$0.39M	0.0%	N/A	0.005%
5/20/2022	The Manufacturers Life Insurance Company	453,283	$10.23M	0.0%	+26.9%	0.141%
5/18/2022	BNP Paribas Arbitrage SA	112,855	$2.56M	0.0%	+2.6%	0.035%
5/17/2022	Walleye Capital LLC	35,925	$0.81M	0.0%	+105.3%	0.011%
5/17/2022	Weiss Multi Strategy Advisers LLC	92,986	$2.11M	0.0%	-1.7%	0.029%
5/17/2022	Advisors Asset Management Inc.	46,163	$1.05M	0.0%	-22.2%	0.014%
5/17/2022	Penn Capital Management Company LLC	86,257	$1.96M	0.2%	+18.4%	0.027%
5/17/2022	Krensavage Asset Management LLC	1,530,406	$34.69M	12.0%	-1.7%	0.477%
5/17/2022	Polar Capital Holdings Plc	2,360,447	$53.51M	0.2%	-46.4%	0.736%
5/17/2022	Royal Bank of Canada	346,455	$7.85M	0.0%	+13.4%	0.108%
5/17/2022	Eaton Vance Management	90,232	$2.05M	0.0%	+244.9%	0.028%
5/17/2022	Ensign Peak Advisors Inc	168,450	$3.82M	0.0%	+11.2%	0.053%
5/17/2022	Farallon Capital Management LLC	10,520,061	$238.49M	1.3%	+18.7%	3.280%
5/17/2022	Great Point Partners LLC	1,300,000	$29.47M	7.1%	-25.7%	0.405%
5/17/2022	Guggenheim Capital LLC	251,597	$5.70M	0.0%	-4.8%	0.078%
5/16/2022	California State Teachers Retirement System	402,586	$9.13M	0.0%	-7.7%	0.126%
5/16/2022	Goldman Sachs Group Inc.	3,250,241	$73.68M	0.0%	+19.1%	1.015%
5/16/2022	Brinker Capital Investments LLC	148,016	$3.36M	0.1%	+8.9%	0.046%
5/16/2022	State Street Corp	11,377,206	$257.92M	0.0%	+0.7%	3.553%
5/16/2022	Eversept Partners LP	203,156	$4.61M	0.4%	-62.1%	0.063%
5/16/2022	Engineers Gate Manager LP	18,785	$0.43M	0.0%	-32.0%	0.006%
5/16/2022	Invesco Ltd.	915,445	$20.75M	0.0%	-11.5%	0.286%
5/16/2022	UBS Group AG	242,097	$5.49M	0.0%	-61.3%	0.076%
5/16/2022	Hsbc Holdings PLC	27,517	$0.63M	0.0%	+67.2%	0.009%
5/13/2022	Renaissance Technologies LLC	16,862,278	$382.27M	0.4%	-1.4%	5.266%
5/13/2022	Bellevue Group AG	2,719,000	$61.64M	0.7%	-4.9%	0.849%
5/13/2022	Ontario Teachers Pension Plan Board	54,793	$1.24M	0.0%	N/A	0.017%
5/13/2022	Northern Trust Corp	2,472,318	$56.05M	0.0%	-2.2%	0.772%
5/13/2022	Charles Schwab Investment Management Inc.	2,952,703	$66.94M	0.0%	+9.0%	0.922%
5/13/2022	Lazard Asset Management LLC	429,299	$9.73M	0.0%	-85.0%	0.134%
5/13/2022	Utah Retirement Systems	55,163	$1.25M	0.0%	-1.8%	0.017%
5/13/2022	Mariner LLC	25,318	$0.57M	0.0%	+16.0%	0.008%
5/13/2022	Penserra Capital Management LLC	15,705	$0.36M	0.0%	N/A	0.005%
5/13/2022	First Trust Advisors LP	3,562,353	$80.76M	0.1%	+30.6%	1.113%
5/13/2022	Prudential Financial Inc.	532,843	$12.08M	0.0%	+53.8%	0.166%
5/13/2022	Federated Hermes Inc.	332,080	$7.53M	0.0%	+190.4%	0.104%
5/13/2022	American International Group Inc.	538,176	$12.20M	0.1%	+0.2%	0.168%
5/13/2022	Bridgewater Associates LP	16,847	$0.38M	0.0%	N/A	0.005%
5/13/2022	Fuller & Thaler Asset Management Inc.	2,682,083	$60.80M	0.4%	-7.3%	0.838%
5/13/2022	Ergoteles LLC	31,838	$0.72M	0.0%	-51.0%	0.010%
5/13/2022	Covestor Ltd	1,676	$38K	0.0%	+245.6%	0.001%
5/13/2022	Zions Bancorporation N.A.	3,327	$75K	0.0%	N/A	0.001%
5/13/2022	Candriam Luxembourg S.C.A.	1,582,316	$35.87M	0.2%	-40.5%	0.494%
5/13/2022	Vanguard Group Inc.	30,268,772	$686.19M	0.0%	+0.7%	9.454%
5/13/2022	Allianz Asset Management GmbH	1,246,076	$28.25M	0.0%	+11.2%	0.389%
5/13/2022	Canada Pension Plan Investment Board	35,405	$0.80M	0.0%	+321.3%	0.011%
5/13/2022	Sei Investments Co.	60,454	$1.36M	0.0%	+124.7%	0.019%
5/13/2022	Blair William & Co. IL	786,444	$17.83M	0.1%	-1.5%	0.246%
5/13/2022	Dimensional Fund Advisors LP	3,730,929	$84.58M	0.0%	+10.3%	1.165%
5/12/2022	LSV Asset Management	567,789	$12.87M	0.0%	N/A	0.177%
5/12/2022	Yousif Capital Management LLC	166,497	$3.77M	0.0%	+1.2%	0.052%
5/12/2022	Great West Life Assurance Co. Can	171,286	$3.99M	0.0%	+7.5%	0.053%
5/12/2022	BlackRock Inc.	32,884,561	$745.49M	0.0%	+1.9%	10.271%
5/12/2022	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	115,956	$2.63M	0.0%	+10.5%	0.036%
5/12/2022	Rhumbline Advisers	824,346	$18.69M	0.0%	-0.3%	0.257%
5/12/2022	MetLife Investment Management LLC	216,333	$4.90M	0.0%	+41.1%	0.068%
5/12/2022	Acadian Asset Management LLC	26,926	$0.61M	0.0%	-17.5%	0.008%
5/12/2022	FORA Capital LLC	13,851	$0.31M	0.1%	N/A	0.004%
5/12/2022	Capital Fund Management S.A.	107,998	$2.45M	0.0%	+11.6%	0.034%
5/12/2022	Bank of Montreal Can	34,494	$0.77M	0.0%	-55.3%	0.011%
5/12/2022	Natixis Advisors L.P.	14,325	$0.33M	0.0%	N/A	0.004%
5/12/2022	E Fund Management Co. Ltd.	12,780	$0.29M	0.0%	+23.3%	0.004%
5/12/2022	AlphaCrest Capital Management LLC	75,583	$1.71M	0.1%	-46.0%	0.024%
5/12/2022	Lingohr & Partner Asset Management GmbH	22,493	$0.51M	1.3%	N/A	0.007%
5/12/2022	Citigroup Inc.	113,789	$2.58M	0.0%	-61.7%	0.036%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	319,044	$7.23M	0.0%	+69.1%	0.100%
5/12/2022	Oppenheimer Asset Management Inc.	47,990	$1.09M	0.0%	+9.0%	0.015%
5/12/2022	HighTower Advisors LLC	29,306	$0.66M	0.0%	-10.3%	0.009%
5/12/2022	Cambridge Investment Research Advisors Inc.	26,714	$0.61M	0.0%	-5.5%	0.008%
5/11/2022	US Bancorp DE	81,866	$1.86M	0.0%	+15.5%	0.026%
5/11/2022	American Century Companies Inc.	1,706,245	$38.68M	0.0%	+3,235.4%	0.533%
5/11/2022	Seven Eight Capital LP	20,368	$0.46M	0.1%	N/A	0.006%
5/11/2022	Bank of New York Mellon Corp	3,129,697	$70.95M	0.0%	+8.1%	0.977%
5/11/2022	Tamarack Advisers LP	200,000	$4.53M	2.1%	N/A	0.062%
5/11/2022	Systematic Financial Management LP	1,152,883	$26.14M	0.8%	+5.4%	0.360%
5/11/2022	Crossmark Global Holdings Inc.	31,310	$0.71M	0.0%	+2.6%	0.010%
5/11/2022	Coldstream Capital Management Inc.	9,135	$0.21M	0.0%	N/A	0.003%
5/11/2022	Handelsbanken Fonder AB	47,466	$1.08M	0.0%	-22.1%	0.015%
5/11/2022	Massachusetts Financial Services Co. MA	72,908	$1.65M	0.0%	-37.9%	0.023%
5/11/2022	State of Tennessee Treasury Department	339,804	$7.70M	0.0%	+143.1%	0.106%
5/11/2022	Twin Tree Management LP	6,591	$0.15M	0.0%	N/A	0.002%
5/11/2022	JPMorgan Chase & Co.	12,046,603	$273.10M	0.0%	+0.9%	3.762%
5/11/2022	WINTON GROUP Ltd	66,321	$1.50M	0.1%	+4.1%	0.021%
5/11/2022	Patriot Financial Group Insurance Agency LLC	37,979	$0.86M	0.2%	-2.0%	0.012%
5/11/2022	GSA Capital Partners LLP	9,637	$0.22M	0.0%	N/A	0.003%
5/10/2022	South Dakota Investment Council	348,666	$7.90M	0.2%	-38.1%	0.109%
5/10/2022	Sectoral Asset Management Inc.	363,840	$8.25M	1.5%	-11.2%	0.114%
5/10/2022	Profund Advisors LLC	54,730	$1.24M	0.1%	-4.8%	0.017%
5/10/2022	ProShare Advisors LLC	64,553	$1.46M	0.0%	-20.4%	0.020%
5/10/2022	TD Asset Management Inc.	720,035	$16.32M	0.0%	-12.5%	0.225%
5/10/2022	AGF Investments LLC	41,739	$0.95M	0.1%	-10.6%	0.013%
5/10/2022	AGF Investments Inc.	12,831	$0.29M	0.0%	-35.3%	0.004%
5/10/2022	Mercer Global Advisors Inc. ADV	31,331	$0.71M	0.0%	+39.2%	0.010%
5/10/2022	Van ECK Associates Corp	58,248	$1.32M	0.0%	N/A	0.018%
5/10/2022	Parametrica Management Ltd	11,594	$0.26M	0.2%	-27.9%	0.004%

Data available starting January 2016

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, it is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human mAb against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $20.82

$20.48

$21.04

50 Day Range

MA: $19.89

$17.44

$22.84

52 Week Range

Now: $20.82

$15.50

$23.40

Volume

2,569,806 shs

Average Volume

2,501,897 shs

Market Capitalization

$6.68 billion

P/E Ratio

22.63

Dividend Yield

N/A

Beta

0.76

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
Lance Willsey (Director)
Vincent T Marchesi (Director)
Jack L Wyszomierski (Director)
Patrick J Haley (EVP)
Charles Cohen (Director)
Alan M Garber (Director)
Carl B Feldbaum (Director)
Christopher J Senner (CFO)
Gisela Schwab (CMO)
Jack L Wyszomierski (Director)
Jeffrey Hessekiel (EVP)
Patrick J Haley (EVP)
Peter Lamb (EVP)
Stelios Papadopoulos (Director)
Learn More about top insider investors at Exelixis.

Trading Isn’t Getting Easier–But Options Just Did!

From Tradewins | Ad

Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!

>>>

EXEL Insider Trading (Exelixis)

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

Exelixis Insider Trading History

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Exelixis?